SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001213900-23-009982
Filing Date
2023-02-10
Accepted
2023-02-09 21:40:39
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-02-10

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea173171-nt10q_inmedphar.htm NT 10-Q 33093
  Complete submission text file 0001213900-23-009982.txt   34140
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: NT 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 23608332
SIC: 2834 Pharmaceutical Preparations